Engineering Microbes for Health and Therapeutic Applications
摘要
Improving microbial strains for health and industrial application is a prospective area of research and economic importance. Cancer biology, molecular microbiology, and microbial bioengineering have spurred the development of engineered probiotics as biotherapeutics for targeted therapy, production of nutraceuticals and recombinant proteins, and probiotic-mediated delivery of drugs to particular tissues. Bioengineered microorganisms have increasing demand in pharmaceutical and process industry.